Vol 9: C-Abl Inhibitor Imatinib Enhances Insulin Production by Cells: C-Abl Negatively Regulates Insulin Production via Interfering with the Expression of NKx2.2 and GLUT-2.Report as inadecuate



 Vol 9: C-Abl Inhibitor Imatinib Enhances Insulin Production by Cells: C-Abl Negatively Regulates Insulin Production via Interfering with the Expression of NKx2.2 and GLUT-2.


Vol 9: C-Abl Inhibitor Imatinib Enhances Insulin Production by Cells: C-Abl Negatively Regulates Insulin Production via Interfering with the Expression of NKx2.2 and GLUT-2. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 9: C-Abl Inhibitor Imatinib Enhances Insulin Production by Cells: C-Abl Negatively Regulates Insulin Production via Interfering with the Expression of NKx2.2 and GLUT-2.
This article is from PLoS ONE, volume 9.AbstractChronic myelogenous leukemia patients treated with tyrosine kinase inhibitor, Imatinib, were shown to have increased serum levels of C-peptide. Imatinib specifically inhibits the tyrosine kinase, c-Abl. However, the mechanism of how Imatinib treatment can lead to increased insulin level is unclear. Sp

Author: Xia, Chang-Qing; Zhang, Pengcheng; Li, Shiwu; Yuan, Lihui; Xia, Tina; Xie, Chao; Clare-Salzler, Michael J.

Source: https://archive.org/



DOWNLOAD PDF




Related documents